| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |